RIPK1-IN-19 is a selective and potent bimodal RIPK1 inhibitor with IC50=15 nM that protects against cell necrosis and works well in the tnf alpha-induced Systemic Inflammatory Response Syndrome (SIRS) model and imiquimod (IMQ)-induced psoriasis model.
Molekulargewicht:
496.54
Reinheit:
98.81%
CAS Nummer:
[2763831-43-0]
Formel:
C28H25FN6O2
Target-Kategorie:
RIP kinase
T87334
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten